NCT03556228 2025-12-11VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLCPhase 1/2 Recruiting242 enrolled
NCT03422679 2024-01-16Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesCellestia Biotech AGPhase 1/2 Terminated79 enrolled 22 charts